SARA STEPHENSON: Open Payments
NPI 1730453200 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 16 payments from 10 companies in 2025. Trend: 2023 $1,938 · 2024 $1,522 · 2025 $371
Food & beverage: $276Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $116 |
| Amgen Inc. | 3 | $52 |
| UCB, Inc. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| ABBVIE INC. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| GENZYME CORPORATION | 1 | $20 |
| Almirall LLC | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $15 |
Products named: TREMFYA, Bimzelx, OTEZLA, Zoryve, CIBINQO, SKYRIZI, DUPIXENT, Seysara.
Industry payments across NE — which companies pay providers there.
